Sleep disorders and the eye

Mayo Clinic Proceedings

Volumn 83, Issue 11, 2008, Pages 1251-1261

  Waller, E Andrew ^a   Bendel, Rick E ^b   Kaplan, Joseph ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTITHROMBOCYTIC AGENT; CORTICOSTEROID; MELATONIN; PLACEBO;

AIRWAY PRESSURE; CIRCADIAN RHYTHM SLEEP DISORDER; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; EYE DISEASE; FLOPPY EYELID SYNDROME; GLAUCOMA; HUMAN; ISCHEMIC OPTIC NEUROPATHY; LAGOPHTHALMOS; MEDLINE; PAPILLEDEMA; PATHOPHYSIOLOGY; REVIEW; SLEEP APNEA SYNDROME; SLEEP DISORDER; VISUAL IMPAIRMENT;

EID: 55549120252     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/83.11.1251     Document Type: Review

References (99)

1. Stevens S, Comella CL, Walters AS, Hening WA. Sleep and wakefulness. In: Goetz CG, ed. Textbook of Clinical Neurology. 2nd ed. Philadelphia, PA: WB Saunders/Elsevier; 2003:19-31.
2. Ellenbogen JM. Cognitive benefits of sleep and their loss due to sleep deprivation. Neurology. 2005;64(7):E25-E27.
3. McEwen BS. Sleep deprivation as a neurobiologic and physiologic stressor: allostasis and allostatic load. Metabolism. 2006;55(10)(suppl 2):S20-S23.
4. Olson EJ, Moore WR, Morgenthaler TI, Gay PC, Staats BA. Obstructive sleep apnea-hypopnea syndrome. Mayo Clin Proc. 2003;78(12):1545-1552.
5. Parish JM, Somers VK. Obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc. 2004;79(8):1036-1046.
6. Wang H, Parker JD, Newton GE, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol. 2007 Apr 17;49(15):1625-1631. Epub 2007 Apr 2.
7. Yumino D, Tsurumi Y, Takagi A, Suzuki K, Kasanuki H. Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol. 2007 Jan 1;99(1):26-30. Epub 2006 Nov 2.
8. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research: the Report of an American Academy of Sleep Medicine Task Force. Sleep. 1999;22(5):667-689.
9. Lattimore JD, Celermajer DS, Wilcox I. Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardiol. 2003;41(9):1429-1437.
10. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353(19):2034-2041.
11. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342(19):1378-1384.
12. Chobanian AV, Bakris GL, Black HR, et al; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report [published correction appears in JAMA. 2003;290(2):197]. JAMA. 2003 May 21;289(19):2560-2572. Epub 2003 May 14.
13. Culbertson WW, Ostler HB. The floppy eyelid syndrome. Am J Ophthalmol. 1981;92(4):568-575.
14. Culbertson WW, Tseng SC. Corneal disorders in floppy eyelid syndrome. Cornea. 1994;13(1):33-42.
15. Donnenfeld ED, Perry HD, Gibralter RP, Ingraham HJ, Udell IJ. Keratoconus associated with floppy eyelid syndrome. Ophthalmology. 1991;98(11):1674-1678.
16. Leibovitch I, Selva D. Floppy eyelid syndrome: clinical features and the association with obstructive sleep apnea. Sleep Med. 2006 Mar;7(2):117-122. Epub 2006 Feb 3.
17. McNab AA. Floppy eyelid syndrome and obstructive sleep apnea. Ophthal Plast Reconstr Surg. 1997;13(2):98-114.
18. McNab AA. The eye and sleep apnea. Sleep Med Rev. 2007;11(4):269-276.
19. Woog JJ. Obstructive sleep apnea and the floppy eyelid syndrome. Am J Ophthalmol. 1990;110(3):314-315.
20. Netland PA, Sugrue SP, Albert DM, Shore JW. Histopathologic features of the floppy eyelid syndrome: involvement of tarsal elastin. Ophthalmology. 1994;101(1):174-181.
21. Schlötzer-Schrehardt U, Stojkovic M, Hofmann-Rummelt C, Cursiefen C, Kruse FE, Holbach LM. The pathogenesis of floppy eyelid syndrome: involvement of matrix metalloproteinases in elastic fiber degradation. Ophthalmology. 2005;112(4):694-704.
22. Taban M, Taban M, Perry JD. Plasma leptin levels in patients with floppy eyelid syndrome. Ophthal Plast Reconstr Surg. 2006;22(5):375-377.
23. Bouloumié A, Drexler HC, Lafontan M, Busse R. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res. 1998;83(10):1059-1066.
24. Park HY, Kwon HM, Lim HJ, et al. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med. 2001;33(2):95-102.
25. Karger RA, White WA, Park WC, et al. Prevalence of floppy eyelid syndrome in obstructive sleep apnea-hypopnea syndrome. Ophthalmology. 2006 Sep;113(9):1669-1674. Epub 2006 Jul 7.
26. McNab AA. The eye and sleep. Clin Experiment Ophthalmol. 2005;33(2):117-125.
27. Mojon DS, Goldblum D, Fleischhauer J, et al. Eyelid, conjunctival, and corneal findings in sleep apnea syndrome. Ophthalmology. 1999;106(6):1182-1185.
28. Robert PY, Adenis JP, Tapie P, Melloni B. Eyelid hyperlaxity and obstructive sleep apnea (O.S.A.) syndrome. Eur J Ophthalmol. 1997;7(3):211-215.
29. Harsch IA, Konturek PC, Koebnick C, et al. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J. 2003;22(2):251-257.
30. Tazaki T, Minoguchi K, Yokoe T, et al. Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2004 Dec 15;170(12):1354-1359. Epub 2004 Sep 10.
31. Kondo S, Kubota S, Shimo T, et al. Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. Carcinogenesis. 2002;23(5):769-776.
32. Tschöp M, Strasburger CJ, Hartmann G, Biollaz J, Bärtsch P. Raised leptin concentrations at high altitude associated with loss of appetite [letter]. Lancet. 1998;352(9134):1119-1120.
33. McNab AA. Reversal of floppy eyelid syndrome with treatment of obstructive sleep apnoea. Clin Experiment Ophthalmol. 2000;28(2):125-126.
34. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363(9422):1711-1720.
35. Khaw PT, Shah P, Elkington AR. Glaucoma - 1: diagnosis [published correction appears in BMJ. 2004;328(7442):762]. BMJ. 2004;328(7431):97-99.
36. Gherghel D, Hosking SL, Orgül S. Autonomic nervous system, circadian rhythms, and primary open-angle glaucoma. Surv Ophthalmol. 2004;49(5):491-508.
37. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):714-720.
38. Mitchell P, Smith W, Attebo K, Healey PR. Prevalence of open-angle glaucoma in Australia: the Blue Mountains Eye Study. Ophthalmology. 1996;103(10):1661-1669.
39. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans: the Baltimore Eye Survey. Arch Ophthalmol. 1991;109(8):1090-1095.
40. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Family history and risk of primary open angle glaucoma: the Baltimore Eye Survey. Arch Ophthalmol. 1994;112(1):69-73.
41. Fechtner RD, Weinreb RN. Mechanisms of optic nerve damage in primary open angle glaucoma. Surv Ophthalmol. 1994;39(1):23-42.
42. Quigley HA, McKinnon SJ, Zack DJ, et al. Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest Ophthalmol Vis Sci. 2000;41(11):3460-3466.
43. Bellezza AJ, Rintalan CJ, Thompson HW, Downs JC, Hart RT, Burgoyne CF. Deformation of the lamina cribrosa and anterior scleral canal wall in early experimental glaucoma. Invest Ophthalmol Vis Sci. 2003;44(2):623-637.
44. Tezel G, Edward DP, Wax MB. Serum autoantibodies to optic nerve head glycosaminoglycans in patients with glaucoma. Arch Ophthalmol. 1999;117(7):917-924.
45. Weinreb RN, Cioffi GA, Harris A. Optic nerve blood flow. In: Van Buskirk EM, Shields MB, eds. 100 Years of Progress in Glaucoma. Philadelphia, PA: Lippincott-Raven; 1997:59-78.
46. Yan X, Tezel G, Wax MB, Edward DP. Matrix metalloproteinases and tumor necrosis factor α in glaucomatous optic nerve head. Arch Ophthalmol. 2000;118(5):666-673.
47. Walsh JT, Montplaisir J. Familial glaucoma with sleep apnoea: a new syndrome? Thorax. 1982;37(11):845-849.
48. Mojon DS, Hess CW, Goldblum D, Böhnke M, Körner F, Mathis J. Primary open-angle glaucoma is associated with sleep apnea syndrome. Ophthalmologica. 2000;214(2):115-118.
49. Mojon DS, Hess CW, Goldblum D, et al. Normal-tension glaucoma is associated with sleep apnea syndrome. Ophthalmologica. 2002;216(3):180-184.
50. Onen SH, Mouriaux F, Berramdane L, Dascotte JC, Kulik JF, Rouland JF. High prevalence of sleep-disordered breathing in patients with primary open-angle glaucoma. Acta Ophthalmol Scand. 2000;78(6):638-641.
51. Girkin CA, McGwin G Jr, McNeal SF, Owsley C. Is there an association between pre-existing sleep apnoea and the development of glaucoma? Br J Ophthalmol. 2006 Jun;90(6):679-681. Epub 2006 Feb 15.
52. Marcus DM, Costarides AP, Gokhale P, et al. Sleep disorders: a risk factor for normal-tension glaucoma? J Glaucoma. 2001;10(3):177-183.
53. Tsang CS, Chong SL, Ho CK, Li MF. Moderate to severe obstructive sleep apnoea patients is associated with a higher incidence of visual field defect. Eye. 2006;20(1):38-42.
54. Mojon DS, Hess CW, Goldblum D, et al. High prevalence of glaucoma in patients with sleep apnea syndrome. Ophthalmology. 1999;106(5):1009-1012.
55. Bendel RE, Kaplan J, Heckman M, Fredrickson PA, Lin SC. Prevalence of glaucoma in patients with obstructive sleep apnoe - a cross-sectional case-series. Eye. 2008 Sep;22(9):1105-1109. Epub 2007 May 4.
56. Geyer O, Cohen N, Segev E, et al. The prevalence of glaucoma in patients with sleep apnea syndrome: same as in the general population. Am J Ophthalmol. 2003;136(6):1093-1096.
57. Sergi M, Salerno DE, Rizzi M, et al. Prevalence of normal tension glaucoma in obstructive sleep apnea syndrome patients. J Glaucoma. 2007;16(1):42-46.
58. Kargi SH, Altin R, Koksal M, et al. Retinal nerve fibre layer measurements are reduced in patients with obstructive sleep apnoea syndrome. Eye. 2005;19(5):575-579.
59. Goldblum D, Mathis J, Böhnke M, et al. Nocturnal measurements of intraocular pressure in patients with normal-tension glaucoma and sleep apnea syndrome [in German]. Klin Monatsbl Augenheilkd. 2000;216(5):246-249.
60. Khaw PT, Shah P, Elkington AR. Glaucoma - 2: treatment. BMJ. 2004;328(7432):156-158.
61. Kremmer S, Niederdräing N, Ayertey HD, Steuhl KP, Selbach JM. Obstructive sleep apnea syndrome, normal tension glaucoma, and nCPAP therapy - a short note. Sleep. 2003;26(2):161-162.
62. Mojon DS, Mathis J, Zulauf M, Koerner F, Hess CW. Optic neuropathy associated with sleep apnea syndrome. Ophthalmology. 1998;105(5):874-877.
63. Sebastian RT, Johns S, Gibson RA. Treating obstructive sleep apnoea syndrome: does it improve visual field changes [letter]? Eye. 2006;20(1):118-120.
64. Li J, McGwin G Jr, Vaphiades MS, Owsley C. Non-arteritic anterior ischaemic optic neuropathy and presumed sleep apnoea syndrome screened by the Sleep Apnea scale of the Sleep Disorders Questionnaire (SA-SDQ). Br J Ophthalmol. 2007 Nov;91(11):1524-1527. Epub 2007 May 15.
65. Rucker JC, Biousse V, Newman NJ. Ischemic optic neuropathies. Curr Opin Neurol. 2004;17(1):27-35.
66. Mojon DS, Hedges TR III, Ehrenberg B, et al. Association between sleep apnea syndrome and nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol. 2002;120(5):601-605.
67. Behbehani R, Mathews MK, Sergott RC, Savino PJ. Nonarteritic anterior ischemic optic neuropathy in patients with sleep apnea while being treated with continuous positive airway pressure. Am J Ophthalmol. 2005;139(3):518-521.
68. Deramo VA, Sergott RC, Augsburger JJ, Foroozan R, Savino PJ, Leone A. Ischemic optic neuropathy as the first manifestation of elevated cholesterol levels in young patients. Ophthalmology. 2003;110(5):1041-1046.
69. Mathews MK. Nonarteritic anterior ischemic optic neuropathy. Curr Opin Ophthalmol. 2005;16(6):341-345.
70. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol. 1994;117(5):603-624.
71. Tesser RA, Niendorf ER, Levin LA. The morphology of an infarct in nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2003;110(10):2031-2035.
72. Palombi K, Renard E, Levy P, et al. Non-arteritic anterior ischaemic optic neuropathy is nearly systematically associated with obstructive sleep apnoea. Br J Ophthalmol. 2006 Jul;90(7):879-882. Epub 2006 Mar 23.
73. Whiting AS, Johnson LN. Papilledema: clinical clues and differential diagnosis. Am Fam Physician. 1992;45(3):1125-1134.
74. Tso MO, Hayreh SS. Optic disc edema in raised intracranial pressure, IV: axoplasmic transport in experimental papilledema. Arch Ophthalmol. 1977;95(8):1458-1462.
75. Wolin MJ, Brannon WL. Disk edema in an overweight woman. Surv Ophthalmol. 1995;39(4):307-314.
76. Bucci FA Jr, Krohel GB. Optic nerve swelling secondary to the obstructive sleep apnea syndrome. Am J Ophthalmol. 1988;105(4):428-430.
77. Purvin VA, Kawasaki A, Yee RD. Papilledema and obstructive sleep apnea syndrome. Arch Ophthalmol. 2000;118(12):1626-1630.
78. Lee AG, Golnik K, Kardon R, Wall M, Eggenberger E, Yedavally S. Sleep apnea and intracranial hypertension in men. Ophthalmology. 2002;109(3):482-485.
79. Peter L, Jacob M, Krolak-Salmon P, et al. Prevalence of papilloedema in patients with sleep apnoea syndrome: a prospective study. J Sleep Res. 2007;16(3):313-318.
80. Sugita Y, Iijima S, Teshima Y, et al. Marked episodic elevation of cerebrospinal fluid pressure during nocturnal sleep in patients with sleep apnea hypersomnia syndrome. Electroencephalogr Clin Neurophysiol. 1985;60(3):214-219.
81. Lee AG. Three questions on the role of sleep apnea syndrome in optic disc edema [letter]. Arch Ophthalmol. 2001;119(8):1225.
82. Stauffer JL, Fayter N, MacLurg BJ. Conjunctivitis from nasal CPAP apparatus [letter]. Chest. 1984;86(5):802.
83. Ely JR, Khorfan F. Unilateral periorbital swelling with nasal CPAP therapy. J Clin Sleep Med. 2006;2(3):330-331.
84. Harrison W, Pence N, Kovacich S. Anterior segment complications secondary to continuous positive airway pressure machine treatment in patients with obstructive sleep apnea. Optometry. 2007;78(7):352-355.
85. Latkany RL, Lock B, Speaker M. Nocturnal lagophthalmos: an overview and classification. Ocul Surf. 2006;4(1):44-53.
86. Lyons CJ, McNab AA. Symptomatic nocturnal lagophthalmos. Aust N Z J Ophthalmol. 1990;18(4):393-396.
87. Fuchs S, Wu FC. Sleep with half-opened eyes (physiological lagophthalmos). Am J Ophthalmol. 1948;1717-1720.
88. Lu BS, Zee PC. Circadian rhythm sleep disorders. Chest. 2006;130(6):1915-1923.
89. Lamberg L. Blind people often sleep poorly: research shines light on therapy. JAMA. 1998;280(13):1123-1124, 1126.
90. Lewy AJ, Newsome DA. Different types of melatonin circadian secretory rhythms in some blind subjects. J Clin Endocrinol Metab. 1983;56(6):1103-1107.
91. Lockley SW, Skene DJ, Arendt J, Tabandeh H, Bird AC, Defrance R. Relationship between melatonin rhythms and visual loss in the blind. J Clin Endocrinol Metab. 1997;82(11):3763-3770.
92. Das A, Sasmal NK, Deb RK, et al. A study of sleeping disorders in blind patients. J Indian Med Assoc. 2006;104(11):619-621, 626.
93. Ionescu D, Driver HS, Heon E, Flanagan J, Shapiro CM. Sleep and daytime sleepiness in retinitis pigmentosa patients. J Sleep Res. 2001;10(4):329-335.
94. Tabandeh H, Lockley SW, Buttery R, et al. Disturbance of sleep in blindness. Am J Ophthalmol. 1998;126(5):707-712.
95. Aldhous ME, Arendt J. Radioimmunoassay for 6-sulphatoxymelatonin in urine using an iodinated tracer. Ann Clin Biochem. 1988;25(pt 3):298-303.
96. Arendt J, Bojkowski C, Franey C, Wright J, Marks V. Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol. J Clin Endocrinol Metab. 1985;60(6):1166-1173.
97. Sack RL, Brandes RW, Kendall AR, Lewy AJ. Entrainment of freerunning circadian rhythms by melatonin in blind people. N Engl J Med. 2000;343(15):1070-1077.
98. Hack LM, Lockley SW, Arendt J, Skene DJ. The effects of low-dose 0.5-mg melatonin on the free-running circadian rhythms of blind subjects. J Biol Rhythms. 2003;18(5):420-429.
99. Skene DJ, Arendt J. Circadian rhythm sleep disorders in the blind and their treatment with melatonin. Sleep Med. 2007 Sep;8(6):651-655. Epub 2007 Apr 8.